CSIMarket
 


Revolution Medicines Inc   (RVMD)
Other Ticker:  
 
 

Revolution Medicines Inc Accounts Receivables Turnover Ratio from the third quarter 2023 to the third quarter 2022

Quarterly Results, Trends, Rankings, Statistics


Revolution Medicines Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the third quarter 2023 to a ratio of 9.11, above the company average. This is a clear sign of healthy business climate in the Biotechnology & Pharmaceuticals industry and improving liquidity at their respective customers, during the third quarter 2023. Average receivable collection period, for the Revolution Medicines Inc in Sep 30 2023 quarter, has decreased to 40 days, compared to 50 days, in the Jun 30 2023 quarter.

If we take a look into Healthcare sector Revolution Medicines Inc achieved the highest receivable turnover ratio. While receivables turnover ratio remained unchanged relative to the previous period at no. .

What is Receivable Turnover Ratio?
What is Revolution Medicines Inc Selling?


What is Receivable Turnover Ratio?




RVMD Receivables Turnover Ratio (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Receivable Change -93.74 % -55.37 % -25.78 % -21.18 % -33.35 %
Y / Y Revenue Change - -58.05 % -7.44 % 62.05 % 204.81 %
Receivable Turnover Ratio (TTM) 9.11 7.33 7.24 6.86 5.4
RVMD's Total Ranking # # # # #
Average receivable collection period 40 50 50 53 68
Seq. Receivable Change -87.69 % -37.17 % -14.51 % -5.4 % -12.16 %
Seq. Revenue Change - -45.48 % -54.25 % 356.79 % -63.19 %


Receivable Turnover Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall Market #

Receivable Turnover Ratio Statistics
High Average Low
0 0 0
 




  News about Revolution Medicines Inc